Safety and Efficacy of 50 mg NYX-783 QD vs. Placebo in PTSD

Summary

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of 50 mg NYX-783 Once Daily Compared to Placebo in Participants with Post-Traumatic Stress Disorder (PTSD)

Timeline

Start

2021-12-13

Primary completion

2023-03-30

Completion

2023-03-30

Drugs

Indications